Novo Nordisk plans to start late-stage trials for experimental obesity drug amycretin-March 2024-www.financetom.com

Novo Nordisk plans to start late-stage trials for experimental obesity drug amycretin

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Novo Nordisk plans to start late-stage trials for experimental obesity drug amycretin

Jun 12, 2025 10:41 AM

June 12 (Reuters) - Novo Nordisk said on

Thursday it plans to start late-stage trials of amycretin

injection and oral drugs during the first quarter of 2026 for

adults who are overweight or obese.

Previous page： Metal Sky Star Acquisition to Buy Fedilco Group Next page： Blackstone to invest $8.2 bln in data centres in northeastern Spain

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Metal Sky Star Acquisition to Buy Fedilco Group

Oct 17, 2024

10:13 AM EDT, 10/15/2024 (MT Newswires) -- Metal Sky Star Acquisition ( MSSA ) said Tuesday it has signed a letter of intent to acquire Fedilco Group, which holds an 80% equity stake in Armenia-based telecommunications company Viva Armenia. Metal Sky Star Acquisition ( MSSA ) will purchase all outstanding shares of Fedilco Group following necessary approvals from Armenian state...

Blackstone to invest $8.2 bln in data centres in northeastern Spain

Oct 17, 2024

MADRID, Oct 15 (Reuters) - Blackstone, the world's largest alternative asset manager, plans to invest 7.5 billion euros ($8.2 billion) to develop data centres in Spain's Aragon, boosting the region's growing status as a major cloud computing hub in Europe. The U.S. private equity fund will follow tech giants such as Microsoft ( MSFT ) and Amazon ( AMZN )...

Kindly MD to Buy Back $500,000 of Shares

Oct 17, 2024

10:04 AM EDT, 10/15/2024 (MT Newswires) -- Kindly MD (KDLY) said Tuesday its board has authorized a repurchase of up to $500,000 of its common shares from time to time, depending on market conditions. Shares of Kindly MD were up 7.5% in recent trading. Price: 1.29, Change: +0.09, Percent Change: +7.50 ...

Update: UnitedHealth's Q3 Adjusted EPS, Revenue Rise; 2024 Profit Outlook Narrows; Shares Fall

Oct 17, 2024

10:13 AM EDT, 10/15/2024 (MT Newswires) -- (Updates with stock move in the headline and first paragraph.) UnitedHealth ( UNH ) shares slumped 9.1% in recent Tuesday trading after the company released Q3 results and narrowed its 2024 adjusted net earnings guidance. Adjusted earnings in the quarter ended Sept. 30 rose to $7.15 per diluted share from $6.56 a year...